Dr SaiVani Yellampalli
drsaivani.bsky.social
Dr SaiVani Yellampalli
@drsaivani.bsky.social
Assistant professor of Nephrology in Santhiram Medical College, Nandyal
Passionate in Preventive Nephrology and Critical Care Nephrology
The common glomerulo nephritis in young in India with heterogeneous presentation still dilemma in treatment
No COI
#NephJc
October 29, 2025 at 1:10 AM
Hi I am Dr Sai vani from India, happy to be part of NephJC chat
Happy learning
#NephJC
October 29, 2025 at 1:06 AM
Is operational tolerance induction finally safe and feasible for some kidney transplant recipients: A breakthrough to a new horizon? - American Journal of Transplantation www.amjtransplant.org/article/S160...
Is operational tolerance induction finally safe and feasible for some kidney transplant recipients: A breakthrough to a new horizon?
Bringing concepts of tolerance induction to clinical reality through advanced-phase randomized controlled trials (RCTs) has been an Achilles heel in organ transplantation since Owen1 and Billingham et...
www.amjtransplant.org
September 29, 2025 at 4:53 PM
Hi, I am Dr Sai vani from India good morning everyone
September 3, 2025 at 1:19 AM
Reposted by Dr SaiVani Yellampalli
Join us for #NephJC 👇🏻
Join us 9/2/25 at 9pm EST.
We will discuss the use of spironolactone in patients on dialysis to prevent t cardiovascular outcomes and heart failure hospitalizations.
Invite your friends. #NephJC #NephSky

www.nephjc.com/news/achieve
In ESRD is spironolactone an overACHIEVEr? — NephJC
This week, we will discuss the ACHIEVE trial. Will spironolactone achieve CV benefits in ESRD?
www.nephjc.com
September 2, 2025 at 2:27 AM
After reading the initial chapter the factors helped tuberculosis to conquer us in initial days is very disheartening, it is the story of many countries not the only henry
August 20, 2025 at 1:24 AM
Hi , I am Dr Saivani
From India, we often come across the Tuberculosis in pulmonary and extra pulmonary forms, in our day to day clinical practise.
I have thouroughly enjoyed reading the book of Everything tuberculosis
#Nephjc
August 20, 2025 at 1:17 AM
Hi, good morning #Nephjc
August 20, 2025 at 1:09 AM
@nephjc.bsky.social
Hi Akshaya
Great job
July 23, 2025 at 2:04 AM
Hi welcome to #nephjc chat on important topic of discordance between eGFR cystatin and eGFR creatinine
July 23, 2025 at 1:06 AM
Reposted by Dr SaiVani Yellampalli
On 7/22/25 at 9pm EST only on Bluesky!
#NephSky #MedSky join us for a lively discussion.
We're debating eGFRdiff (the gap that is sometimes present between the eGFR of cystatin C and creatinine). What does it mean, what causes it and what you should do about it. #NephJC
www.nephjc.com/news/egfrdiff
Mind The Gap: When eGFR Creatinine and Cystatin C Disagree — NephJC
This week, we will discuss the clinical significance of eGFRdiff, the difference in eGFRcys (cystatin C) and eGFRcr (creatinine).
www.nephjc.com
July 21, 2025 at 11:31 AM
@nephjc.bsky.social
Hi I am Dr Sai vani
I am also interested to combine both
July 9, 2025 at 1:26 AM
Hi an interesting discussion on flozins n finerenone in confident trial
July 9, 2025 at 1:14 AM
Hi everyone
July 9, 2025 at 1:07 AM
Reposted by Dr SaiVani Yellampalli
T0a:
CKD is rising, yet still flies under the radar—underdiagnosed, undertreated, and underserved

Awareness helps, but outcomes won’t improve without scalable solutions that move beyond education and into action

#NephJC
June 25, 2025 at 1:07 AM
Reposted by Dr SaiVani Yellampalli
⏰ One hour to go until #NephJC chat

As @glaucomflecken.bsky.social vividly mirrors, primary care docs are swamped. What if, few days earlier 👨‍⚕️ got an email saying: “In diabetes, HTN, eGFR <60, review SGLT2i.” Now, in front of pt with DM, eGFR of 45, it clicks 💡

www.youtube.com/watc...
Family Medicine Goes to Therapy
Learn how to say no
www.youtube.com
June 25, 2025 at 12:00 AM